Stoke Therapeutics, Inc. (FRA:0GT)
Germany · Delayed Price · Currency is EUR 26.60
-0.40 (-1.48%)
At close: Jan 2, 2026
Stoke Therapeutics Market Cap
Stoke Therapeutics has a market cap or net worth of €1.61 billion as of January 9, 2026. Its market cap has increased by 172.73% in one year.
Market Cap
1.61B
Enterprise Value
1.33B
Revenue
175.26M
Ranking
n/a
PE Ratio
46.65
Stock Price
€26.60
Market Cap Chart
Since June 19, 2019, Stoke Therapeutics's market cap has increased from 717.17M to 1.61B, an increase of 124.92%. That is a compound annual growth rate of 13.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 1.61B | 4.47% |
| Dec 31, 2025 | 1.54B | 173.62% |
| Dec 31, 2024 | 564.30M | 165.56% |
| Dec 29, 2023 | 212.49M | -37.60% |
| Dec 30, 2022 | 340.54M | -56.12% |
| Dec 31, 2021 | 776.08M | -57.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 240.49B |
| Siemens Aktiengesellschaft | 195.73B |
| Allianz SE | 148.37B |
| Deutsche Telekom AG | 134.57B |
| Siemens Energy AG | 105.59B |
| Rheinmetall AG | 84.93B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.21B |
| Deutsche Bank Aktiengesellschaft | 63.34B |